Literature DB >> 8140196

A significant increase in lithium levels after concomitant ACE inhibitor administration.

M Teitelbaum1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8140196     DOI: 10.1016/S0033-3182(93)71851-4

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  7 in total

1.  The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?

Authors:  Leif Hommers; Matthias Fischer; Christine Reif-Leonhard; Bruno Pfuhlmann; Jürgen Deckert; Stefan Unterecker
Journal:  Clin Drug Investig       Date:  2019-05       Impact factor: 2.859

Review 2.  Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

Authors:  K L Goa; M Haria; M I Wilde
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

3.  Lithium Toxicity from the Addition of an ACE Inhibitor with an Unexpected Type I Brugada Pattern ECG: Case Files of the Medical Toxicology Fellowship at the University of California, San Diego.

Authors:  Aaron Schneir; Clifford P Masom
Journal:  J Med Toxicol       Date:  2020-04-15

Review 4.  Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.

Authors:  K L Goa; J A Balfour; G Zuanetti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 5.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 6.  Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 7.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.